The record
| Buyer | Novartis |
|---|---|
| Target | Tourmaline Bio |
| Sector | Pharma & life sciences |
| Direction | Outbound (swiss buyer, foreign target) |
| Value | USD 48 per share |
| Announced | September 2025 |
| Status | Completed |
| Detail | Completed 28 October 2025 |
| Source | Novartis |
On the Ledger
One of 7 pharma and life sciences transactions on the Ledger. Novartis is a party to 2 of the 24 transactions we track.